SARS-CoV-2, Spike S1, RBD mutant (K529E, D614G) Plasmid, pCDNA3.1(+).

SARS-CoV-2, Spike S2 mutant (L1203F) Plasmid, pCDNA3.1(+).

SARS-CoV-2, Spike S1 mutant (L54F, D614G) Plasmid, pCDNA3.1(+).

SARS-CoV-2, Spike S1 mutant (L54F) Plasmid, pCDNA3.1(+).

SARS-CoV-2, Spike S1 mutant (L5F, D614G) Plasmid, pCDNA3.1(+).

Creative Biolabs provides professional PK/PD evaluation services for non-IgG therapeutic antibodies by using a variety of techniques.

Creative Biolabs provides extensive characterization services for non-IgG therapeutic antibodies by using a variety of techniques.

Creative Biolabs provides a full range of high-quality non-IgG antibody drug conjugates service based on our top-ranking technical platforms.

Creative Biolabs provides custom services about non-IgG therapeutic antibodies application for disease therapy according to customer's detailed requirements.

Creative Biolabs provides YWHAQ engineered antibodies such as therapeutic antibodies, nanobodies, bispecific antibodies and intrabodies. We also provide antibody / peptide libraries, Biosimilar cell lines, Chimeric antigen receptor (CAR) products, antibody-drug conjugates (ADCs)